The Role of Dopamine in Schizophrenia from a Neurobiological and Evolutionary Perspective: Old Fashioned, but Still in Vogue
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Dopamine in Schizophrenia from a Neurobiological and Evolutionary Perspective: Old Fashioned, but Still in Vogue
Authors
Keywords
-
Journal
Frontiers in Psychiatry
Volume 5, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-05-19
DOI
10.3389/fpsyt.2014.00047
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Schizophrenia: from dopaminergic to glutamatergic interventions
- (2014) Marc Laruelle CURRENT OPINION IN PHARMACOLOGY
- Clozapine, a Fast-Off-D2 Antipsychotic
- (2013) Philip Seeman ACS Chemical Neuroscience
- Impaired Prefrontal-Basal Ganglia Functional Connectivity and Substantia Nigra Hyperactivity in Schizophrenia
- (2013) Jong H. Yoon et al. BIOLOGICAL PSYCHIATRY
- Selective Overexpression of Dopamine D3 Receptors in the Striatum Disrupts Motivation but not Cognition
- (2013) Eleanor H. Simpson et al. BIOLOGICAL PSYCHIATRY
- The Neurobiology of Thought: The Groundbreaking Discoveries of Patricia Goldman-Rakic 1937-2003
- (2013) A. F. T. Arnsten CEREBRAL CORTEX
- Disruption of Glutamate-Glutamine-GABA Cycle Significantly Impacts on Suicidal Behaviour: Survey of the Literature and Own Findings on Glutamine Synthetase.
- (2013) Hans-Gert Bernstein et al. CNS & Neurological Disorders-Drug Targets
- Do Subjects at Clinical High Risk for Psychosis Differ from those with a Genetic High Risk? - A Systematic Review of Structural and Functional Brain Abnormalities
- (2013) R. Smieskova et al. CURRENT MEDICINAL CHEMISTRY
- Abnormal Striatal Dopamine Transmission in Schizophrenia
- (2013) Jerome Brunelin et al. CURRENT MEDICINAL CHEMISTRY
- The potential role of dopamine D3 receptor neurotransmission in cognition
- (2013) Shinichiro Nakajima et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Dopamine D3 receptor antagonists: a patent review (2007 – 2012)
- (2013) Fabrizio Micheli et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Optimal Extent of Dopamine D2 Receptor Occupancy by Antipsychotics for Treatment of Dopamine Supersensitivity Psychosis and Late-Onset Psychosis
- (2013) Masaomi Iyo et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- PET neuroimaging of extrastriatal dopamine receptors and prefrontal cortex functions
- (2013) Hidehiko Takahashi JOURNAL OF PHYSIOLOGY-PARIS
- The Chlorpromazine Enigma
- (2013) Alan A. Baumeister Journal of the History of the Neurosciences
- History of the Discovery of the Antipsychotic Dopamine D2 Receptor: A Basis for the Dopamine Hypothesis of Schizophrenia
- (2013) Bertha K. Madras Journal of the History of the Neurosciences
- Dopamine D3 receptor antagonism—still a therapeutic option for the treatment of schizophrenia
- (2013) Gerhard Gross et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Direct and indirect interactions of the dopamine D3 receptor with glutamate pathways: implications for the treatment of schizophrenia
- (2013) Pierre Sokoloff et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- D-Amphetamine and Antipsychotic Drug Effects on Latent Inhibition in Mice Lacking Dopamine D2 Receptors
- (2013) C Bay-Richter et al. NEUROPSYCHOPHARMACOLOGY
- Effects of COMT genotype on sensory gating and its modulation by nicotine: Differences in low and high P50 suppressors
- (2013) S. de la Salle et al. NEUROSCIENCE
- Localized infusions of the partial alpha 7 nicotinic receptor agonist SSR180711 evoke rapid and transient increases in prefrontal glutamate release
- (2013) D.M. Bortz et al. NEUROSCIENCE
- COMT and MTHFR polymorphisms interaction on cognition in schizophrenia: An exploratory study
- (2013) Dimitrios Kontis et al. NEUROSCIENCE LETTERS
- Deletion of the NMDA-NR1 receptor subunit gene in the mouse nucleus accumbens attenuates apomorphine-induced dopamine D1 receptor trafficking and acoustic startle behavior
- (2013) Michael J. Glass et al. SYNAPSE
- Cholinergic connectivity: it's implications for psychiatric disorders
- (2013) Elizabeth Scarr et al. Frontiers in Cellular Neuroscience
- Neural Basis for the Ability of Atypical Antipsychotic Drugs to Improve Cognition in Schizophrenia
- (2013) Tomiki Sumiyoshi et al. Frontiers in Behavioral Neuroscience
- Evolutionary aspects of human exercise—Born to run purposefully
- (2012) Mark P. Mattson AGEING RESEARCH REVIEWS
- Glutamate Receptor Abnormalities in Schizophrenia: Implications for Innovative Treatments
- (2012) Maria D. Rubio et al. Biomolecules & Therapeutics
- COMT polymorphisms as predictors of cognitive dysfunction during manic and mixed episodes in bipolar I disorder
- (2012) Márcio Gerhardt Soeiro-de-Souza et al. BIPOLAR DISORDERS
- Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine
- (2012) Marisa Möller et al. BRAIN BEHAVIOR AND IMMUNITY
- Modafinil disrupts prepulse inhibition in mice: Strain differences and involvement of dopaminergic and serotonergic activation
- (2012) Perrin Kwek et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effects of novel, high affinity glycine transport inhibitors on frontostriatal dopamine release in a rodent model of schizophrenia
- (2012) Andrea Balla et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar mania
- (2012) Frank I Tarazi et al. Expert Opinion on Drug Discovery
- Interaction between effects of genes coding for dopamine and glutamate transmission on striatal and parahippocampal function
- (2012) Andreina Pauli et al. HUMAN BRAIN MAPPING
- Recent Advances in Imaging of Dopaminergic Neurons for Evaluation of Neuropsychiatric Disorders
- (2012) Lie-Hang Shen et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Nucleus Accumbens and Dopamine-Mediated Turning Behavior of the Rat: Role of Accumbal Non-dopaminergic Receptors
- (2012) Hiroko Ikeda et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Calcium-Dependent Networks in Dopamine–Glutamate Interaction: The Role of Postsynaptic Scaffolding Proteins
- (2012) Andrea de Bartolomeis et al. MOLECULAR NEUROBIOLOGY
- Dopaminergic Modulation of Synaptic Transmission in Cortex and Striatum
- (2012) Nicolas X. Tritsch et al. NEURON
- Evidence for involvement of nitric oxide and GABAB receptors in MK-801- stimulated release of glutamate in rat prefrontal cortex
- (2012) Nicole L. Roenker et al. NEUROPHARMACOLOGY
- Chronic Adolescent Exposure to Delta-9-Tetrahydrocannabinol in COMT Mutant Mice: Impact on Indices of Dopaminergic, Endocannabinoid and GABAergic Pathways
- (2012) Áine T Behan et al. NEUROPSYCHOPHARMACOLOGY
- Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia
- (2012) Natalie Matosin et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Post-weaning social isolation and subchronic NMDA glutamate receptor blockade: Effects on locomotor activity and GABA signaling in the rat suggest independent mechanisms
- (2012) Andrea J. Hickey et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Effects of Dopamine D2 Receptor Partial Agonist Antipsychotic Aripiprazole on Dopamine Synthesis in Human Brain Measured by PET with L-[β-11C]DOPA
- (2012) Hiroshi Ito et al. PLoS One
- Cariprazine, a dopamine D3-receptor-preferring partial agonist, blocks phencyclidine-induced impairments of working memory, attention set-shifting, and recognition memory in the mouse
- (2012) Ross Zimnisky et al. PSYCHOPHARMACOLOGY
- Serotonin–glutamate and serotonin–dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins
- (2012) A. de Bartolomeis et al. PSYCHOPHARMACOLOGY
- Twenty-five Years of Glutamate in Schizophrenia: Are We There Yet?
- (2012) D. C. Javitt SCHIZOPHRENIA BULLETIN
- Schizophrenia in Translation: Dissecting Motivation in Schizophrenia and Rodents
- (2012) E. H. Simpson et al. SCHIZOPHRENIA BULLETIN
- Capturing the Angel in "Angel Dust": Twenty Years of Translational Neuroscience Studies of NMDA Receptor Antagonists in Animals and Humans
- (2012) B. Moghaddam et al. SCHIZOPHRENIA BULLETIN
- Antipsychotics, dopamine D2 receptor occupancy and clinical improvement in schizophrenia: A meta-analysis
- (2012) Zeynep Yilmaz et al. SCHIZOPHRENIA RESEARCH
- Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2mg/day, but does not enhance efficacy of haloperidol, 2mg/day: Comparison with reference dose risperidone, 6mg/day
- (2012) Herbert Y. Meltzer et al. SCHIZOPHRENIA RESEARCH
- COMT influences on prefrontal and striatal blood oxygenation level-dependent responses during working memory among individuals with schizophrenia, their siblings, and healthy controls
- (2012) Alan Ceaser et al. Cognitive Neuropsychiatry
- Dopamine D2 Antagonist-Induced Striatal Nur77 Expression Requires Activation of mGlu5 Receptors by Cortical Afferents
- (2012) Jérôme Maheux et al. Frontiers in Pharmacology
- Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET study
- (2011) Claire Leroy et al. ADDICTION BIOLOGY
- Differential neuronal changes in medial prefrontal cortex, basolateral amygdala and nucleus accumbens after postweaning social isolation
- (2011) Yu-Chun Wang et al. Brain Structure & Function
- The role of serotonin receptors in the action of atypical antipsychotic drugs
- (2011) HY Meltzer et al. CURRENT OPINION IN PHARMACOLOGY
- Prefrontal cortical network connections: key site of vulnerability in stress and schizophrenia
- (2011) Amy F.T. Arnsten INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
- RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients
- (2011) Jagadeesh Sridhara Rao et al. JOURNAL OF AFFECTIVE DISORDERS
- Antipsychotic-Associated Mental Side Effects and Their Relationship to Dopamine D2 Receptor Occupancy in Striatal Subdivisions
- (2011) Jong-Hoon Kim et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Dopamine D2 Receptor Occupancy and Clinical Effects
- (2011) Hiroyuki Uchida et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- I. In vivo evidence for partial agonist effects of (−)-OSU6162 and (+)-OSU6162 on 5-HT2A serotonin receptors
- (2011) Maria L. Carlsson et al. JOURNAL OF NEURAL TRANSMISSION
- Clozapine functions through the prefrontal cortex serotonin 1A receptor to heighten neuronal activity via calmodulin kinase II-NMDA receptor interactions
- (2011) Sudarshana Purkayastha et al. JOURNAL OF NEUROCHEMISTRY
- Antipsychotic Drugs Rapidly Induce Dopamine Neuron Depolarization Block in a Developmental Rat Model of Schizophrenia
- (2011) O. Valenti et al. JOURNAL OF NEUROSCIENCE
- Dopamine D2 Receptor Activity Modulates Akt Signaling and Alters GABAergic Neuron Development and Motor Behavior in Zebrafish Larvae
- (2011) B. R. Souza et al. JOURNAL OF NEUROSCIENCE
- Increased prefrontal cortical D1 receptors in drug naïve patients with schizophrenia: a PET study with [11C]NNC112
- (2011) Anissa Abi-Dargham et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Circumstantial evidence for a role of glutamine-synthetase in suicide
- (2011) Hans O. Kalkman MEDICAL HYPOTHESES
- Dopamine system dysregulation by the hippocampus: Implications for the pathophysiology and treatment of schizophrenia
- (2011) Anthony A. Grace NEUROPHARMACOLOGY
- Higher Levels of Glutamate in the Associative-Striatum of Subjects with Prodromal Symptoms of Schizophrenia and Patients with First-Episode Psychosis
- (2011) Camilo de la Fuente-Sandoval et al. NEUROPSYCHOPHARMACOLOGY
- Purinergic signalling: From normal behaviour to pathological brain function
- (2011) Geoffrey Burnstock et al. PROGRESS IN NEUROBIOLOGY
- Negative modulation of GABAA α5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats
- (2011) John P. Redrobe et al. PSYCHOPHARMACOLOGY
- Cognition in schizophrenia: core psychological and neural mechanisms
- (2011) Deanna M. Barch et al. TRENDS IN COGNITIVE SCIENCES
- Targeting glutamate synapses in schizophrenia
- (2011) Julie R. Field et al. TRENDS IN MOLECULAR MEDICINE
- Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia
- (2011) Daniel J. Lodge et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Beyond cAMP: the regulation of Akt and GSK3 by dopamine receptors
- (2011) Jean-Martin Beaulieu Frontiers in Molecular Neuroscience
- Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
- (2010) Lawrence S. Kegeles et al. ARCHIVES OF GENERAL PSYCHIATRY
- Executive functions and selective attention are favored in middle-aged healthy women carriers of the Val/Val genotype of the catechol-o-methyltransferase gene: a behavioral genetic study
- (2010) Silvia Solís-Ortiz et al. Behavioral and Brain Functions
- Dopamine D2 and 5-hydroxytryptamine 5-HT2A receptors assemble into functionally interacting heteromers
- (2010) Dasiel O. Borroto-Escuela et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Striatal and Extrastriatal Dopamine D2/D3 Receptors in Schizophrenia Evaluated With [18F]fallypride Positron Emission Tomography
- (2010) Lawrence S. Kegeles et al. BIOLOGICAL PSYCHIATRY
- Presynaptic Dopamine in Schizophrenia
- (2010) Nobumi Miyake et al. CNS Neuroscience & Therapeutics
- Antipsychotic Occupancy of Dopamine Receptors in Schizophrenia
- (2010) Magdalena Nord et al. CNS Neuroscience & Therapeutics
- Cannabinoid-Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders
- (2010) Javier Fernández-Ruiz et al. CNS Neuroscience & Therapeutics
- Acetylcholine-Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders
- (2010) Deranda B Lester et al. CNS Neuroscience & Therapeutics
- All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors
- (2010) Philip Seeman CNS Neuroscience & Therapeutics
- Enhanced dopamine function in DISC1-L100P mutant mice: implications for schizophrenia
- (2010) T. V. Lipina et al. GENES BRAIN AND BEHAVIOR
- Basal ganglia pathology in schizophrenia: dopamine connections and anomalies
- (2010) Emma Perez-Costas et al. JOURNAL OF NEUROCHEMISTRY
- Positron Emission Tomography in Schizophrenia: A New Perspective
- (2010) N. H. Patel et al. JOURNAL OF NUCLEAR MEDICINE
- Sex-specific proteome differences in the anterior cingulate cortex of schizophrenia
- (2010) Daniel Martins-de-Souza et al. JOURNAL OF PSYCHIATRIC RESEARCH
- The treatment of cognitive impairment in schizophrenia
- (2010) Donald C. Goff et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Dopaminergic Dysfunction in Schizophrenia: Salience Attribution Revisited
- (2010) A. Heinz et al. SCHIZOPHRENIA BULLETIN
- Antipsychotic Dosing: How Much but also How Often?
- (2010) G. Remington et al. SCHIZOPHRENIA BULLETIN
- l-Stepholidine-induced excitation of dopamine neurons in rat ventral tegmental area is associated with its 5-HT1A receptor partial agonistic activity
- (2010) Ming Gao et al. SYNAPSE
- Hyperactive mice show elevated D2Highreceptors, a model for schizophrenia: Calcium/calmodulin-dependent kinase II alpha knockouts
- (2010) Gabriela Novak et al. SYNAPSE
- Schizophrenia, amphetamine-induced sensitized state and acute amphetamine exposure all show a common alteration: increased dopamine D2 receptor dimerization
- (2010) Min Wang et al. Molecular Brain
- Arvid Carlsson, and the story of dopamine
- (2010) VikramK Yeragani et al. Indian Journal of Psychiatry
- The prefrontal cortex: a target for antipsychotic drugs
- (2009) F. Artigas ACTA PSYCHIATRICA SCANDINAVICA
- Dopamine–glutamate abnormalities in the frontal cortex associated with the catechol-O-methyltransferase (COMT) in schizophrenia
- (2009) Ralf Brisch et al. BRAIN RESEARCH
- Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortex
- (2009) S Yamamura et al. BRITISH JOURNAL OF PHARMACOLOGY
- Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging
- (2009) O. Howes et al. CURRENT PHARMACEUTICAL DESIGN
- Effects of atypical (risperidone) and typical (haloperidol) antipsychotic agents on astroglial functions
- (2009) André Quincozes-Santos et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy
- (2009) Hans-Gert Bernstein et al. Expert Review of Neurotherapeutics
- Glutamatergic (N-Methyl-D-aspartate Receptor) Hypofrontality in Schizophrenia: Too Little Juice or a Miswired Brain?
- (2009) G. J. Marek et al. MOLECULAR PHARMACOLOGY
- GABAB/NMDA receptor interaction in the regulation of extracellular dopamine levels in rodent prefrontal cortex and striatum
- (2009) Andrea Balla et al. NEUROPHARMACOLOGY
- Functional differences between D1 and D5 revealed by high resolution imaging on live neurons
- (2009) M. Kruusmägi et al. NEUROSCIENCE
- Altered reward functions in patients on atypical antipsychotic medication in line with the revised dopamine hypothesis of schizophrenia
- (2009) Henrik Walter et al. PSYCHOPHARMACOLOGY
- Schizophrenia model of elevated D2High receptors: Haloperidol reverses the amphetamine-induced elevation in dopamine D2High
- (2009) Philip Seeman SCHIZOPHRENIA RESEARCH
- Serotonergic hyperinnervation and effective serotonin blockade in an FGF receptor developmental model of psychosis
- (2009) Ilona Klejbor et al. SCHIZOPHRENIA RESEARCH
- Evaluation of the antipsychotic effect of bi-acetylated l-stepholidine (l-SPD-A), a novel dopamine and serotonin receptor dual ligand
- (2009) Yang Guo et al. SCHIZOPHRENIA RESEARCH
- Arvid Carlsson: An Early Pioneer in Translational Medicine
- (2009) J. K. Andersen Science Translational Medicine
- Glutamate agonist LY404,039 for treating schizophrenia has affinity for the dopamine D2Highreceptor
- (2009) Philip Seeman et al. SYNAPSE
- A Critique of the Dopamine Hypothesis of Schizophrenia and Psychosis
- (2009) Joanna Moncrieff HARVARD REVIEW OF PSYCHIATRY
- The Dual-State Theory of Prefrontal Cortex Dopamine Function with Relevance to Catechol-O-Methyltransferase Genotypes and Schizophrenia
- (2008) Daniel Durstewitz et al. BIOLOGICAL PSYCHIATRY
- Less Is More: Antipsychotic Drug Effects Are Greater with Transient Rather Than Continuous Delivery
- (2008) Anne-Noël Samaha et al. BIOLOGICAL PSYCHIATRY
- Receptor–receptor interactions within receptor mosaics. Impact on neuropsychopharmacology
- (2008) K. Fuxe et al. BRAIN RESEARCH REVIEWS
- Quantitative Analysis of the Expression of Dopamine D1 and D2 Receptors in Pyramidal and GABAergic Neurons of the Rat Prefrontal Cortex
- (2008) N. Santana et al. CEREBRAL CORTEX
- Glutamatergic dysfunction in schizophrenia: From basic neuroscience to clinical psychopharmacology
- (2008) Rodrigo D. Paz et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Molecular mechanisms of stress-induced prefrontal cortical impairment: Implications for mental illness
- (2008) A. B. Hains et al. LEARNING & MEMORY
- Interaction between N-methyl-d-aspartic acid receptors and D1 dopamine receptors: An important mechanism for brain plasticity
- (2008) L. Scott et al. NEUROSCIENCE
- Association analysis of the glutamic acid decarboxylase 2 and the glutamine synthetase genes (GAD2, GLUL) with schizophrenia
- (2008) Shinsaku Arai et al. PSYCHIATRIC GENETICS
- Glutamate agonists for schizophrenia stimulate dopamine D2High receptors
- (2008) Philip Seeman SCHIZOPHRENIA RESEARCH
- Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia
- (2008) Amy E. Steffek et al. SCHIZOPHRENIA RESEARCH
- Dopamine D2Highreceptors moderately elevated by bifeprunox and aripiprazole
- (2008) Philip Seeman SYNAPSE
- Glutamate receptor mGlu2 and mGlu3 knockout striata are dopamine supersensitive, with elevated D2Highreceptors and marked supersensitivity to the dopamine agonist (+)PHNO
- (2008) Philip Seeman et al. SYNAPSE
- Dopamine D2Highreceptors measured ex vivo are elevated in amphetamine-sensitized animals
- (2008) Philip Seeman SYNAPSE
- Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia
- (2008) John E. Lisman et al. TRENDS IN NEUROSCIENCES
- Adaptive properties and heterogeneity of dopamine D2 receptors – Pharmacological implications
- (2007) Arvid Carlsson et al. BRAIN RESEARCH REVIEWS
- Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: Implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function
- (2007) Henry Sershen et al. NEUROCHEMISTRY INTERNATIONAL
- Dopamine D2 receptor radiotracers [11C](+)-PHNO and [3H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo
- (2007) Patrick N. McCormick et al. NUCLEAR MEDICINE AND BIOLOGY
- Dopaminergic neurones: much more than dopamine?
- (2005) Vincent Seutin BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More